358 related articles for article (PubMed ID: 28008176)
21. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
22. Daratumumab utilization and cost analysis among patients with multiple myeloma in a US community oncology setting.
Gordan LN; Marks SM; Xue M; Nagovski N; Lambert JH; Smith RE
Future Oncol; 2022 Jan; 18(3):301-309. PubMed ID: 34709061
[TBL] [Abstract][Full Text] [Related]
23. Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy.
Gonzalez-McQuire S; Yong K; Leleu H; Mennini FS; Flinois A; Gazzola C; Schoen P; Campioni M; DeCosta L; Fink L
J Med Econ; 2018 May; 21(5):450-467. PubMed ID: 29278014
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Drayson MT; Bowcock S; Planche T; Iqbal G; Pratt G; Yong K; Wood J; Raynes K; Higgins H; Dawkins B; Meads D; Hulme CT; Whittaker AC; Hawkey P; Low E; Dunn JA
Health Technol Assess; 2019 Nov; 23(62):1-94. PubMed ID: 31690402
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients with Heavily Pretreated Relapsed-refractory Multiple Myeloma in the United States.
Pelligra CG; Parikh K; Guo S; Chandler C; Mouro J; Abouzaid S; Ailawadhi S
Clin Ther; 2017 Oct; 39(10):1986-2005.e5. PubMed ID: 28967482
[TBL] [Abstract][Full Text] [Related]
26. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
[TBL] [Abstract][Full Text] [Related]
27. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
Burger CD; Ozbay AB; Lazarus HM; Riehle E; Montejano LB; Lenhart G; White RJ
J Manag Care Spec Pharm; 2018 Aug; 24(8):834-842. PubMed ID: 29436260
[TBL] [Abstract][Full Text] [Related]
28. Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.
Ishak KJ; Caro JJ; Drayson MT; Dimopoulos M; Weber D; Augustson B; Child JA; Knight R; Iqbal G; Dunn J; Shearer A; Morgan G
Value Health; 2011; 14(5):672-8. PubMed ID: 21839405
[TBL] [Abstract][Full Text] [Related]
29. Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
Blimark CH; Turesson I; Genell A; Ahlberg L; Björkstrand B; Carlson K; Forsberg K; Juliusson G; Linder O; Mellqvist UH; Nahi H; Kristinsson SY;
Haematologica; 2018 Mar; 103(3):506-513. PubMed ID: 29217784
[TBL] [Abstract][Full Text] [Related]
30. Interferon-alpha treatment in multiple myeloma: meta-analysis of 30 randomised trials among 3948 patients.
Fritz E; Ludwig H
Ann Oncol; 2000 Nov; 11(11):1427-36. PubMed ID: 11142483
[TBL] [Abstract][Full Text] [Related]
31. Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma.
Ailawadhi S; DerSarkissian M; Duh MS; Lafeuille MH; Posner G; Ralston S; Zagadailov E; Ba-Mancini A; Rifkin R
Clin Ther; 2019 Mar; 41(3):477-493.e7. PubMed ID: 30773308
[TBL] [Abstract][Full Text] [Related]
32. Phase-Specific and Lifetime Costs of Multiple Myeloma Among Older Adults in the US.
Bhattacharya K; Bentley JP; Ramachandran S; Chang Y; Banahan BF; Shah R; Bhakta N; Yang Y
JAMA Netw Open; 2021 Jul; 4(7):e2116357. PubMed ID: 34241627
[TBL] [Abstract][Full Text] [Related]
33. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings.
Black J; Reaven NL; Funk SE; McGaughey K; Ohayon M; Guilleminault C; Ruoff C; Mignot E
Sleep Med; 2014 May; 15(5):522-9. PubMed ID: 24768358
[TBL] [Abstract][Full Text] [Related]
34. Combined submyeloablative and myeloablative dose intense melphalan results in satisfactory responses with acceptable toxicity in patients with multiple myeloma.
Novitzky N; Thomson J; Thomas V; du Toit C; Mohamed Z; McDonald A
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1402-10. PubMed ID: 20385248
[TBL] [Abstract][Full Text] [Related]
35. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century.
Pulte D; Jansen L; Castro FA; Emrich K; Katalinic A; Holleczek B; Brenner H;
Br J Haematol; 2015 Oct; 171(2):189-196. PubMed ID: 26123295
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
Evans LA; Go R; Warsame R; Nandakumar B; Buadi FK; Dispenzieri A; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Kourelis TV; Russell S; Lust JA; Lin Y; Siddiqui M; Kyle RA; Gertz MA; Rajkumar SV; Kumar S; Gonsalves WI
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):451-460.e2. PubMed ID: 33785296
[TBL] [Abstract][Full Text] [Related]
37. Lenalidomide maintenance post-transplantation in newly diagnosed multiple myeloma: real-world outcomes and costs.
Hari P; Ung B; Abouzaid S; Agarwal A; Parikh K
Future Oncol; 2019 Dec; 15(35):4045-4056. PubMed ID: 31625415
[No Abstract] [Full Text] [Related]
38. Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost.
Suzuki K
Int J Hematol; 2020 Apr; 111(4):512-518. PubMed ID: 32125606
[TBL] [Abstract][Full Text] [Related]
39. Trends in medical care costs--rapid increases continue.
Vincenzino JV
Stat Bull Metrop Insur Co; 1991; 72(1):2-11. PubMed ID: 1901429
[TBL] [Abstract][Full Text] [Related]
40. Bortezomib in multiple myeloma.
Cecchi M; Caccese E; Messori A
N Engl J Med; 2005 Sep; 353(12):1297-8; author reply 1297-8. PubMed ID: 16177258
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
